0.000USD0.000Pre-market 07/24, 09:30 (ET)
42.14BMarket Cap
38.53P/E TTM
Key Figures
153.355Open
154.280High
1.61MVolume
38.53P/E TTM
11.33P/E Dynamic
4.180Dividend TTM
0.58%Turnover Ratio
153.160Prev. Close
152.135Low
128.24MTurnover
25.11P/E Static
1.75P/B
2.73%Div Yield TTM
3.13%ROA
187.35052wk High
1.00Volume Ratio
1.68BNet Profit
275.54MShares
3.9693EPS TTM
0.23Beta
6.67%ROE
127.53652wk Low
1.40%Amplitude
46.58%Gross Margin
42.14BMarket Cap
2.46Reward/Risk
1.48%Risk Rate
Currency: USD Updated: 2026-07-23 Key Insights
Becton Dickinson and Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 185.39.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Becton Dickinson and Co's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Becton Dickinson and Co Highlights
StrengthsRisks
Becton Dickinson and Co News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Becton Dickinson and Co
BDX
16
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Becton Dickinson and Co Info
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Ticker SymbolBDX
CompanyBecton Dickinson and Co
CEOPolen (Thomas E)
Websitehttps://www.bd.com/
Shareholders
FAQs
What is the current price of Becton Dickinson and Co (BDX)?
The current price of Becton Dickinson and Co (BDX) is 152.94.
What is the symbol of Becton Dickinson and Co?
The ticker symbol of Becton Dickinson and Co is BDX.
What is the 52-week high of Becton Dickinson and Co?
The 52-week high of Becton Dickinson and Co is 187.35.
What is the 52-week low of Becton Dickinson and Co?
The 52-week low of Becton Dickinson and Co is 127.54.
What is the market capitalization of Becton Dickinson and Co?
The market capitalization of Becton Dickinson and Co is 42.14B.
Is Becton Dickinson and Co (BDX) currently rated as Buy, Hold, or Sell?
According to analysts, Becton Dickinson and Co (BDX) has an overall rating of Buy, with a price target of 185.39.
What is the Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX)?
The Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX) is 5.83.